The Berlin-based insurtech wefox Holding has announced that it has successfully reached an agreement for its Series D funding round, increasing its post-money valuation to USD 4.5 bn. The equity round was led by Mubadala Investment
Tags :Eduard de Zordi
Nestlé has issued CHF 1.5 bn Bonds last 15th July and Credit Suisse, UBS and Zürcher Kantonalbank have acted as lead managers. The bonds will be listed on the SIX Swiss Exchange. The transaction consists
Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
Julius Baer Group has placed a perpetual non-cumulative Additional Tier 1 (AT1) securities in a USD 400 million transaction with private banks and institutional investors in Asia and Europe. The transaction will help to optimise Julius Baer
Sonova Holding, providers of hearing aid solutions, has completed the placement of CHF 450 million Bonds governed by Swiss law. Application will be made for the Bonds to be listed on the SIX Swiss Exchange. The
Roche Kapitalmarkt issued CHF 3 billion Bonds guaranteed by Roche Holding. BNP Paribas (Suisse), Credit Suisse, Deutsche Bank and UBS acted as lead managers. The bonds will be listed on the SIX Swiss Exchange. The transaction
Berner Kantonalbank has successfully completed the placement of CHF 200 m 0.85 per cent. Tier 2 bonds. Zürcher Kantonalbank acted as Structuring Advisor and Lead Manager and Berner Kantonalbank acted as Co-Manager. The bonds will be listed
Implenia, a construction and real estate service provider, has successfully completed its issuance of CHF 175 million Bonds on November 26, 2021. The Bonds will be listed on the SIX Swiss Exchange. Homburger acted as counsel to
SIX Group successfully placed CHF 150 million Dual Part Digital Bonds. The Bonds will be listed on the SDX Trading and the SIX Swiss Exchange with SIX Digital Exchange and SIX SIS as CSDs. The company
Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
